RADiant provides surface radiation therapy treatment for a wide range of superficial skin conditions, including basal and squamous cell carcinoma. RADiant is the first dual-modality system designed for dermatologists to offer both electronic brachytherapy and superficial radiation therapy. In this webinar, Dr. Steven Davis, medical director of The Dermatology & Laser Center of San Antonio, describes these modalities, patient selection criteria, and outcomes. Dr. Davis has performed more than 25,000 skin cancer operations and chose Xstrahl’s RADiant system to expand his practice.
Xstrahl Announces Landmark Education Program for SARRP Users to Advance Preclinical Radiation Research
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions. Visit Xstrahl at booth 220 at the ACRO Summit 2025 – The Radiation Oncology Summit located at Planet Hollywood, Las Vegas, NV from March 12-15, 2025.
